132 related articles for article (PubMed ID: 12235253)
1. Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms.
Woolverton WL; Ranaldi R; Wang Z; Ordway GA; Paul IA; Petukhov P; Kozikowski A
J Pharmacol Exp Ther; 2002 Oct; 303(1):211-7. PubMed ID: 12235253
[TBL] [Abstract][Full Text] [Related]
2. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
Woolverton WL; Wang Z
Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
[TBL] [Abstract][Full Text] [Related]
4. Reinforcing effect of pseudoephedrine isomers and the mechanism of action.
Wee S; Ordway GA; Woolverton WL
Eur J Pharmacol; 2004 Jun; 493(1-3):117-25. PubMed ID: 15189772
[TBL] [Abstract][Full Text] [Related]
5. High affinity hydroxypiperidine analogues of 4-(2-benzhydryloxyethyl)-1-(4-fluorobenzyl)piperidine for the dopamine transporter: stereospecific interactions in vitro and in vivo.
Ghorai SK; Cook C; Davis M; Venkataraman SK; George C; Beardsley PM; Reith ME; Dutta AK
J Med Chem; 2003 Mar; 46(7):1220-8. PubMed ID: 12646032
[TBL] [Abstract][Full Text] [Related]
6. Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.
Kozikowski AP; Johnson KM; Deschaux O; Bandyopadhyay BC; Araldi GL; Carmona G; Munzar P; Smith MP; Balster RL; Beardsley PM; Tella SR
J Pharmacol Exp Ther; 2003 Apr; 305(1):143-50. PubMed ID: 12649362
[TBL] [Abstract][Full Text] [Related]
7. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
Wilcox KM; Kimmel HL; Lindsey KP; Votaw JR; Goodman MM; Howell LL
Synapse; 2005 Dec; 58(4):220-8. PubMed ID: 16206183
[TBL] [Abstract][Full Text] [Related]
8. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
10. A reduced rate of in vivo dopamine transporter binding is associated with lower relative reinforcing efficacy of stimulants.
Wee S; Carroll FI; Woolverton WL
Neuropsychopharmacology; 2006 Feb; 31(2):351-62. PubMed ID: 15957006
[TBL] [Abstract][Full Text] [Related]
11. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary characterization of a high-affinity novel radioligand for the dopamine transporter.
Dutta AK; Reith ME; Madras BK
Synapse; 2001 Feb; 39(2):175-81. PubMed ID: 11180505
[TBL] [Abstract][Full Text] [Related]
14. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
[TBL] [Abstract][Full Text] [Related]
15. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
16. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
17. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
Carroll FI; Runyon SP; Abraham P; Navarro H; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Dec; 47(25):6401-9. PubMed ID: 15566309
[TBL] [Abstract][Full Text] [Related]
18. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
19. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
20. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
